Provided by Tiger Trade Technology Pte. Ltd.

Agenus

3.56
0.0000
Post-market: 3.580.0200+0.56%16:29 EDT
Volume:255.57K
Turnover:921.39K
Market Cap:136.70M
PE:-1.05K
High:3.68
Open:3.60
Low:3.54
Close:3.56
52wk High:7.34
52wk Low:1.38
Shares:38.40M
Float Shares:35.64M
Volume Ratio:0.50
T/O Rate:0.72%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.0034
EPS(LYR):-10.5913
ROE:-1278.83%
ROA:-5.67%
PB:-0.50
PE(LYR):-0.34

Loading ...

Agenus reports biomarker data showing survival stratification in MSS mCRC patients treated with botensilimab plus balstilimab

Reuters
·
Feb 20

Agenus stellt neue klinische Daten zu Botensilimab bei therapieresistenten Tumoren vor

Reuters
·
Feb 10

Analysts Offer Insights on Healthcare Companies: Argenx Se (ARGX), Agenus (AGEN) and Assertio Therapeutics (ASRT)

TIPRANKS
·
Jan 21

Agenus Expands Medical Affairs Infrastructure Amid Rising Demand for Botensilimab Access

Reuters
·
Jan 21

Agenus Launches Stakeholder Webcast Showcasing Global Momentum for BOT+BAL Program

Reuters
·
Jan 21

Agenus Inc. Files Initial Beneficial Ownership Statement for Principal Accounting Officer Austin Charette

Reuters
·
Jan 17

Agenus Forms Major Strategic Collaboration with Zydus Lifesciences

TIPRANKS
·
Jan 16

Agenus Falls After $141M Zydus Deal Closes

Dow Jones
·
Jan 16

Zydus Lifesciences Closes Acquisition of Agenus Biologics Facilities and Launches Zylidac Bio in US

Reuters
·
Jan 15

Agenus Closes $141M Strategic Collaboration with Zydus Lifesciences

Reuters
·
Jan 15

Agenus Consolidates Financial Leadership With Interim CFO Appointment

TIPRANKS
·
Jan 15

Agenus Inc - Effective Jan 8, Appointed CEO Garo Armen as Interim CFO - SEC Filing

THOMSON REUTERS
·
Jan 15

Agenus Names CEO Garo Armen as Interim CFO, Appoints Austin Charette as Principal Accounting Officer

Reuters
·
Jan 15

Agenus Inc - France's Ansm Approves Updated Protocol for Botensilimab + Balstilimab

THOMSON REUTERS
·
Jan 12

Agenus Inc - BOT+Bal Remains Investigational, Not Approved for Marketing in France or Elsewhere

THOMSON REUTERS
·
Jan 12

France Expands Compassionate Access for Agenus Botensilimab and Balstilimab Combination

Reuters
·
Jan 12

Agenus amends Ligand agreement, modifies warrant holder rights

TIPRANKS
·
Jan 09

Agenus Reports Promising Results for Botensilimab and Balstilimab in Refractory Ovarian Cancer Trial

Reuters
·
Dec 23, 2025

NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:33 AM

Reuters
·
Dec 19, 2025

Agenus Drops in Volume Spike, Last Down 5.1%

THOMSON REUTERS
·
Dec 03, 2025